Skip to main content
. 2022 Mar;11(3):420–431. doi: 10.21037/tlcr-22-190

Figure 1.

Figure 1

Study flow diagram of the selection process of eligible cases. NMA, non-mucinous adenocarcinoma; IMA, invasive mucinous adenocarcinoma.